| |
| |
|
| Insider
Information: |
Kolchinsky Peter |
| Relationship: |
Director, 10% Owner |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
21 |
|
| Direct
Shares |
6,648,738 |
|
|
Indirect Shares
|
89,615,900 |
|
|
| Direct
Value |
$30,628,641 |
|
|
|
Indirect Value
|
$946,611,696 |
|
|
| Total
Shares |
96,264,638 |
|
|
| Total
Value |
$977,240,337 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 14.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aradigm Corp |
ARDM |
10% Owner |
2007-03-01 |
0 |
2008-01-15 |
7,681,410 |
Premium* |
|
|
Curis Inc |
CRIS |
10% Owner |
2008-04-15 |
0 |
2008-04-15 |
6,250,564 |
Premium* |
|
|
Sequenom Inc |
SQNM |
10% Owner |
|
0 |
2008-06-06 |
4,617,766 |
Premium* |
|
|
Biospecifics Technologies Corp |
BSTC |
10% Owner |
2008-12-29 |
0 |
2009-04-14 |
825,844 |
Premium* |
|
|
Lipid Sciences Inc |
LIPD |
10% Owner |
2008-03-27 |
0 |
2008-03-27 |
3,705,312 |
Premium* |
|
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
2013-09-30 |
4,816,562 |
2014-09-11 |
13,000,000 |
Premium* |
|
|
Sangamo Biosciences Inc |
SGMO |
Former 10% Owner |
2014-08-01 |
1,829,426 |
2013-07-17 |
0 |
Premium* |
|
|
Aclaris Therapeutics, Inc. |
ACRS |
10% Owner |
2015-10-07 |
0 |
2015-10-21 |
2,314,942 |
Premium* |
|
|
Ra Pharmaceuticals, Inc. |
RARX |
Director, 10% Owner |
2016-10-31 |
0 |
2020-04-02 |
0 |
Premium* |
|
|
Kalvista Pharmaceuticals Inc |
KALV |
Director, 10% Owner |
2016-11-21 |
0 |
2017-10-12 |
1,441,070 |
Premium* |
|
|
G1 Therapeutics Inc |
GTHX |
Fmr 10% Owner See Foot... |
2017-05-22 |
0 |
2017-05-22 |
2,684,244 |
Premium* |
|
|
Kala Pharmaceuticals, Inc. |
KALA |
Director, 10% Owner |
2017-07-25 |
0 |
2020-03-13 |
10,874,613 |
Premium* |
|
|
Wave Life Sciences Ltd. |
WVE |
Director, 10% Owner |
2017-11-13 |
0 |
2019-01-24 |
7,775,207 |
Premium* |
|
|
Dicerna Pharmaceuticals Inc |
DRNA |
Director |
2017-12-18 |
0 |
2019-12-02 |
0 |
Premium* |
|
|
Eidos Therapeutics, Inc. |
EIDX |
10% Owner |
2018-06-22 |
0 |
2018-06-22 |
2,162,671 |
Premium* |
|
|
Arvinas Holding Company, Llc |
ARVN |
Former 10% Owner |
2018-10-01 |
0 |
2018-10-01 |
3,138,412 |
Premium* |
|
|
Synthorx, Inc. |
THOR |
Director, 10% Owner |
2018-12-11 |
0 |
2020-01-23 |
0 |
Premium* |
|
|
Satsuma Pharmaceuticals, Inc. |
STSA |
Former 10% Owner |
2019-09-17 |
0 |
2023-06-08 |
0 |
Premium* |
|
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
10% Owner |
|
0 |
2019-10-16 |
5,422,312 |
Premium* |
|
|
Forma Therapeutics Holdings, Inc., |
FMTX |
Director, 10% Owner |
2021-06-17 |
2,750 |
2021-06-17 |
9,011,651 |
Premium* |
|
|
Solid Biosciences Inc |
SLDB |
Director, 10% Owner |
|
0 |
2020-12-10 |
8,709,882 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
207 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-07-01 |
4 |
S |
$15.96 |
$1,323,999 |
D/D |
(82,700) |
2,162,538 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner. |
– – – |
2014-01-09 |
4 |
S |
$18.28 |
$1,329,365 |
D/D |
(72,440) |
3,970,562 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
10% Owner |
– – • |
2013-09-24 |
4 |
S |
$7.30 |
$1,330,789 |
D/D |
(181,429) |
5,230,711 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-07-30 |
4 |
S |
$12.35 |
$1,361,606 |
D/D |
(109,590) |
1,857,196 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-03-28 |
4 |
B |
$17.07 |
$1,436,056 |
D/D |
84,000 |
4,317,200 |
2.44 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-02-26 |
4 |
B |
$19.15 |
$1,452,243 |
D/D |
74,194 |
3,757,196 |
2.44 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-03-06 |
4 |
S |
$24.10 |
$1,481,538 |
D/D |
(61,483) |
3,683,000 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Director |
– • – |
2018-03-19 |
4 |
D |
$12.46 |
$1,501,638 |
I/I |
(119,370) |
4,342,943 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-07-24 |
4 |
S |
$12.28 |
$1,523,235 |
D/D |
(124,050) |
2,075,703 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-03-03 |
4 |
S |
$18.21 |
$1,529,902 |
D/D |
(84,000) |
3,683,000 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Director |
– • – |
2018-11-08 |
4 |
D |
$14.86 |
$1,603,680 |
I/I |
(107,920) |
2,456,669 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-03-13 |
4 |
B |
$22.76 |
$1,623,356 |
D/D |
71,319 |
3,683,000 |
2.44 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-06-05 |
4 |
S |
$14.13 |
$1,626,669 |
D/D |
(115,102) |
2,714,339 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-03-25 |
4 |
B |
$19.33 |
$1,631,041 |
D/D |
84,000 |
3,767,000 |
2.44 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-04-30 |
4 |
B |
$13.29 |
$1,674,679 |
D/D |
124,500 |
4,774,672 |
2.44 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-04-11 |
4 |
B |
$14.48 |
$1,694,299 |
D/D |
116,992 |
4,723,633 |
2.44 |
- |
|
| CRIS |
Curis Inc |
10% Owner |
– – • |
2008-04-15 |
4 |
S |
$1.40 |
$1,820,000 |
I/I |
(1,300,000) |
6,250,564 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-04-08 |
4 |
B |
$15.49 |
$1,888,274 |
D/D |
121,876 |
4,596,900 |
2.44 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-03-06 |
4 |
B |
$22.45 |
$1,890,245 |
D/D |
84,001 |
3,683,000 |
2.44 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Director |
– • – |
2018-03-20 |
4 |
D |
$11.00 |
$1,924,823 |
I/I |
(173,185) |
4,169,758 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-06-06 |
4 |
S |
$14.07 |
$1,930,949 |
D/D |
(135,101) |
2,579,238 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-03-18 |
4 |
S |
$23.74 |
$1,994,573 |
D/D |
(84,000) |
3,683,000 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Former 10% Owner |
– – – |
2014-05-28 |
4 |
S |
$13.42 |
$1,996,952 |
D/D |
(148,689) |
4,168,834 |
0 |
- |
|
| ACHN |
Achillion Pharmaceuticals... |
10% Owner |
– – • |
2014-08-28 |
4 |
S |
$11.51 |
$1,999,372 |
I/I |
(173,641) |
15,366,014 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Director |
– • – |
2018-03-21 |
4 |
D |
$11.07 |
$2,021,509 |
I/I |
(180,969) |
3,988,789 |
0 |
- |
|
207 Records found
|
|
Page 6 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
